Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice

Behavioural Brain Research

Volumn 183, Issue 1, 2007, Pages 95-100

  Rehni, Ashish K ^a   Singh, Nirmal ^a   Jaggi, Amteshwar S ^a   Singh, Manjeet ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Amniotic fluid; Cerebral ischaemia; Sources; Stem cells

Indexed keywords

AMNIOTIC FLUID CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; ISCHEMIA; MAZE TEST; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SCORING SYSTEM; SOMATOSENSORY DISORDER; STEM CELL;

AMNIOTIC FLUID; ANIMALS; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; EXPLORATORY BEHAVIOR; FEMALE; GROOMING; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; LOCOMOTION; MALE; MAZE LEARNING; MICE; MULTIPOTENT STEM CELLS; POSTURAL BALANCE; RECOVERY OF FUNCTION; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 34547902839     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.05.028     Document Type: Article

References (47)

1. Assady S., Maor G., Amit M., Itskovitz-Eldor J., Skorecki K.L., and Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 50 (2001) 1691-1697
2. Baker K., Bucay Marcus C., Huffman K., Kruk H., Malfroy B., and Doctrow S.R. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther 284 (1998) 215-221
3. Bhardwaj A., Alkayed N.J., and Hurn. Mechanism of ischaemic brain damage. Curr Sci 5 (2003) 160-167
4. Borlongan C.V., Randall T.S., Cahill D.W., and Sanberg P.R. Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test. Brain Res 676 (1995) 231-234
5. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
6. Chen Y., Constantini S., Trembovler V., Weinstock M., and Shohami E. An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 13 (1996) 557-568
7. Chenard B.L., and Menniti F.S. Antagonists selective for NMDA receptors containing the NR2B subunit. Curr Pharmacol Des 5 (1999) 381-404
8. Dahlke M.H., Popp F.C., Bahlmann F.H., Aselmann H., Jager M.D., Neipp M., et al. Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: do bone marrow-derived cells contribute?. J Hepatol 39 (2003) 365-373
9. Dhingra D., Parle M., and Kulkarni S.K. Effect of combination of insulin with dextrose D (-) fructose and diet on learning and memory in mice. Indian J Pharmacol 91 (2003) 361-365
10. Dobkin B.H. The rehabilitation of elderly stroke patients. Clin Geriat Med 7 (1991) 507-523
11. Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
12. Fischer G., Mutel V., and Trube G. Ro 25-6981, a highly potent and selective blocker of N-methyl-d-aspartate receptors containing the NR2B subunit characterization in vitro. J Pharmacol Exp Ther 283 (1997) 1285-1292
13. Germano A.F., Dixon C.E., d'Avella D., Hayes R.L., and Tomasello F. Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J Neurotrauma 11 (1994) 345-353
14. Gupta R., Singh M., and Sharma A. Neuroprotective effect of antioxidants on ischaemia/reperfusion-induced cerebral injury. Pharmacol Res 48 2 (2003) 209-215
15. Haley T.J., and McCormic W.G. Pharmacological effect produced by intracerebral injection of drugs in conscious mouse. Br J Pharmacol Chemother 12 (1957) 12-15
16. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W.K., Gordon P.L., Neel M., et al. Transplantability and therapeutic effects of bone marrow derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5 (1999) 309-313
17. in't Anker P.S., Scherjon S.A., van der Keur C.K., Noort W.A., Claas F.H.J., Willemze R., et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102 (2003) 1548-1549
18. Intercollegiate Stroke Working Party. National Clinical Guidelines for Stroke. Royal College of Physicians of London; 2004. p. 31-50.
19. Itoh J., Nabeshima T., and Kameyama T. Utility of an elevated plus maze for the evaluation of memory in mice. Effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 101 (1990) 27-32
20. Jenkins L.W., Povlishock J.T., Lewelt W., Miller J.D., and Becker D.P. The role of postischemic recirculation in the development of ischemic neuronal injury following complete cerebral ischemia. Acta Neuropathol 5 (1981) 205-220
21. Jeong S.W., Chu K., Jung K.H., Kim S.U., Kim M., and Roh J.K. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 4 (2003) 2258-2263
22. Johansson B.B. Functional outcome in rats transferred to an enriched environment 15 days after focal brain ischemia. Stroke 27 (1996) 324-326
23. Mooney C. The Republican war on science (2005), Basic Books, New York, NY
24. Park K.I. Transplantation of neural stem cells: cellular and gene therapy for hypoxic-ishcemic brain injury. Yonsei Med J 41 (2000) 825-835
25. Polgar S., Morris M.E., Reilly S., Bilney B., and Sanberg P.R. Reconstructive neurosurgery for Parkinson's disease: a systematic review and preliminary meta-analysis. Brain Res Bull 60 (2003) 1-24
26. Prusa A.R., Marton E., Rosner M., Bernaschek G., and Hengstschlager M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum Reprod 18 7 (2003) 1489-1493
27. Reddy D.S., and Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effect of neurosteroids on aging and dizocilpine induced learning impairment. Brain Res 799 (1998) 215-229
28. Rehni A.K., and Singh N. Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep 59 (2007) 197-203
29. Rogers D.C., Campbell C.A., Stretton J.L., and Mackay K.B. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 28 (1997) 2060-2066
30. Savitz S.I., Dinsmore J.H., Wechsler L.R., Rosenbaum D.M., and Caplan L.R. Cell therapy for stroke. NeuroRx 1 4 (2004) 406-414
31. Sawamoto K., Wichterle H., Gonzalez-Perez O., Cholfin J.A., Yamada M., Spassky N., et al. New neurons follow the flow of cerebrospinal fluid in the adult brain. Science 311 5761 (2006) 629-632
32. Schäbitz W.R., Schwab S., Spranger M., and Hacke W. Intraventricular BDNF reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 17 (1997) 500-508
33. Schallert T., Kozlowski D.A., Humm J.L., and Cocke R.R. Use-dependent structural events in recovery of function. Adv Neurol 73 (1997) 229-238
34. Shohami E., Novikov M., and Bass R. Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res 674 (1995) 55-62
35. Singh N., Sharma A., and Singh M. Possible mechanism of alprazolam induced amnesia in mice. Pharmacology 56 (1998) 46-50
36. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
37. Tsai M.S., Hwang S.M., Tsai Y.L., Cheng F.C., Lee J.L., and Chang Y.J. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 74 (2006) 545-551
38. Vasudevan M., and Parle M. Pharmacological actions of Thespesia Populenia relevant to Alzheimer's disease. Phytomedicine 13 (2006) 677-687
39. Warner D.S., Sheng H., and Batinic'-Haberle I. Oxidants, antioxidants and the ischemic brain. J Exp Biol 207 (2004) 3221-3231
40. Welsh F.A., Sakamoto T., McKee A.E., and Sims R.E. Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J Neurochem 49 (1987) 846-851
41. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M., and Roswell K.L. Estradiol is a protective factor in the adult and aging brain. Brain Res Rev 37 (2001) 313-319
42. Wojcik C., and Napoli M.D. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Stroke 35 (2004) 1506-1518
43. World Health Organisation. Cerebrovascular disorders: a clinical and research, classification vol. 43 (1978), World Health Organization, Geneva
44. Whisnant J.H. The decline of stroke. Stroke 15 (1984) 160-168
45. Yamashita K., Wiessner C., Lindholm D., Thoenen H., and Hossmann K.A. Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat. Metab Brain Dis 12 (1997) 271-280
46. Yan J., Xu L., Welsh A.M., Chen D., Hazel T., Johe K., et al. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24 8 (2006) 1976-1985
47. Zhang L., Chen J., Li Y., Zhang Z.G., and Chopp M. Quantitative measurement of motor and somatosensory impairments mild (30 min) and severe (2 h) transient middle cerebral artery occlusion in rats. J Neurol Sci 174 (2000) 141-146